Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung Adenocarcinoma.

Kubota, Masaomi; Tamura, Nobumasa; Hayashi, Takaaki; Nishijima, Euido; Yanagisawa, Haruhiko; Kojima, Akira; Nakano, Tadashi

Kubota, Masaomi; Tamura, Nobumasa; Hayashi, Takaaki; Nishijima, Euido; Yanagisawa, Haruhiko; Kojima, Akira; Nakano, Tadashi.

Afiliação

Kubota M; Department of Ophthalmology, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2, Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Tamura N; Department of Respiratory Medicine, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2, Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Hayashi T; Department of Ophthalmology, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2, Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Nishijima E; Department of Ophthalmology, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo 105-8461, Japan.
Yanagisawa H; Department of Respiratory Medicine, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2, Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Kojima A; Department of Respiratory Medicine, Katsushika Medical Center, The Jikei University School of Medicine, 6-41-2, Aoto, Katsushika-ku, Tokyo 125-8506, Japan.
Nakano T; Department of Ophthalmology, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo 105-8461, Japan.

Case Rep Ophthalmol Med ; 2021: 2832021, 2021.

Article em En | MEDLINE | ID: mdl-34327032

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Case Rep Ophthalmol Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google